z-logo
Premium
Better reporting of safety data in clinical trials of biologic drugs in psoriasis is still needed
Author(s) -
DávilaSeijo P.
Publication year - 2021
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/bjd.19434
Subject(s) - psoriasis , medicine , clinical trial , intensive care medicine , medline , dermatology , political science , law
Linked Article:   Afach et al. Br J Dermatol 2021; 184 :415–424.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom